Beacon Biosignals

Private

Combines FDA-cleared wearable EEG technology with advanced AI to capture and analyze real-world neural data, enabling breakthroughs across neurology, psychiatry, and sleep medicine. Building the world's largest neurodiagnostic dataset. Making brain function measurable and actionable at scale.

Founders Jacob Donoghue

CEO Jacob Donoghue

Company

Founded

2019

Headquarters

Boston, United States

Financials

Total Funding

$132M

Sectors

Artificial Intelligence Healthtech Biotech

beacon.bio

Funding History

4 rounds

Series B Apr 6, 2026

$11M

JSL Health Palo Santo VC Kicker Ventures Samsung Next

Series B Nov 13, 2025

$86M

Innoviva (Lead) GV Nexus NeuroTech Ventures S32 Catalio Capital Management Takeda General Catalyst Logos Capital Casdin Capital Indicator Ventures

Series A Feb 1, 2022

$32M

General Catalyst (Lead) Casdin Capital Indicator Ventures

Seed Jun 1, 2020

$3M

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.